wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q50636722-D2B4F14E-04AB-4B0B-AFDC-AB6F1F0E4299
Q50636722-D2B4F14E-04AB-4B0B-AFDC-AB6F1F0E4299
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50636722-D2B4F14E-04AB-4B0B-AFDC-AB6F1F0E4299
Discovery of Fevipiprant (NVP-QAW039), a Potent and Selective DP2 Receptor Antagonist for Treatment of Asthma.
P2860
Q50636722-D2B4F14E-04AB-4B0B-AFDC-AB6F1F0E4299
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50636722-D2B4F14E-04AB-4B0B-AFDC-AB6F1F0E4299
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
678a39e21f61156ed7e1fae44e5b72b55dc2bf7f
P2860
Pharmacokinetics, Safety, and Tolerability of Fevipiprant (QAW039), a Novel CRTh2 Receptor Antagonist: Results From 2 Randomized, Phase 1, Placebo-Controlled Studies in Healthy Volunteers.